Canlyniadau Chwilio - Gay, Francesca

Checkpoint inhibitors and myeloma: promises, deadlocks and new directions gan Bertamini, Luca, Gay, Francesca

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Autologous transplant for myeloma: when the old meets the new gan Gay, Francesca, Genuardi, Mariella, Boccadoro, Mario

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma gan Bonello, Francesca, Mina, Roberto, Boccadoro, Mario, Gay, Francesca

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Emerging drugs and combinations to treat multiple myeloma gan Larocca, Alessandra, Mina, Roberto, Gay, Francesca, Bringhen, Sara, Boccadoro, Mario

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate? gan Leleu, Xavier, Gay, Francesca, Flament, Anne, Allcott, Kim, Delforge, Michel

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Moving Toward Continuous Therapy in Multiple Myeloma gan Bonello, Francesca, Cetani, Giusy, Bertamini, Luca, Gay, Francesca, Larocca, Alessandra

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma gan Oliva, Stefania, Troia, Rossella, D'Agostino, Mattia, Boccadoro, Mario, Gay, Francesca

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies gan D’Agostino, Mattia, Bertamini, Luca, Oliva, Stefania, Boccadoro, Mario, Gay, Francesca

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Editorial: Exploiting the Immune System to Treat Multiple Myeloma: From Transplantation to Novel Treatment Approaches gan van de Donk, Niels W. C. J., Kastritis, Efstathios, Gay, Francesca

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR gan Weisel, Katja, Mateos, Maria-Victoria, Gay, Francesca, Delforge, Michel, Cook, Gordon, Szabo, Zsolt, Desgraz, Renaud, DeCosta, Lucy, Moreau, Philippe

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma gan Mateos, María-Victoria, Bladé, Joan, Bringhen, Sara, Ocio, Enrique M, Efebera, Yvonne, Pour, Luděk, Gay, Francesca, Sonneveld, Pieter, Gullbo, Joachim, Richardson, Paul G.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib gan Gambella, Manuela, Rocci, Alberto, Passera, Roberto, Gay, Francesca, Omedè, Paola, Crippa, Claudia, Corradini, Paolo, Romano, Alessandra, Rossi, Davide, Ladetto, Marco, Boccadoro, Mario, Palumbo, Antonio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy gan Bruno, Giulia, Bringhen, Sara, Maffei, Ilaria, Iannaccone, Andrea, Crea, Teresa, Ravera, Agnese, Astarita, Anna, Vallelonga, Fabrizio, Salvini, Marco, Gay, Francesca, Veglio, Franco, Milan, Alberto

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Early versus Delayed Autologous Transplantation Following IMiD-based Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma gan Kumar, Shaji, Lacy, Martha Q., Dispenzieri, Angela, Buadi, Francis K., Hayman, Suzanne R., Dingli, David, Gay, Francesca, Sinha, Shirshendu, Leung, Nelson, Hogan, William, Rajkumar, S. Vincent, Gertz, Morie A

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies gan Caltagirone, Simona, Ruggeri, Marina, Aschero, Simona, Gilestro, Milena, Oddolo, Daniela, Gay, Francesca, Bringhen, Sara, Musolino, Caterina, Baldini, Luca, Musto, Pellegrino, Petrucci, Maria T., Gaidano, Gianluca, Passera, Roberto, Bruno, Benedetto, Palumbo, Antonio, Boccadoro, Mario, Omedè, Paola

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction gan Astarita, Anna, Mingrone, Giulia, Airale, Lorenzo, Vallelonga, Fabrizio, Covella, Michele, Catarinella, Cinzia, Cesareo, Marco, Bruno, Giulia, Leone, Dario, Giordana, Carlo, Cetani, Giusy, Salvini, Marco, Gay, Francesca, Bringhen, Sara, Rabbia, Franco, Veglio, Franco, Milan, Alberto

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients gan Mingrone, Giulia, Astarita, Anna, Airale, Lorenzo, Maffei, Ilaria, Cesareo, Marco, Crea, Teresa, Bruno, Giulia, Leone, Dario, Avenatti, Eleonora, Catarinella, Cinzia, Salvini, Marco, Cetani, Giusy, Gay, Francesca, Bringhen, Sara, Veglio, Franco, Vallelonga, Fabrizio, Milan, Alberto

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial gan Palumbo, Antonio, Larocca, Alessandra, Genuardi, Mariella, Kotwica, Katarzyna, Gay, Francesca, Rossi, Davide, Benevolo, Giulia, Magarotto, Valeria, Cavallo, Federica, Bringhen, Sara, Rus, Cecilia, Masini, Luciano, Iacobelli, Massimo, Gaidano, Gianluca, Mitsiades, Constantine, Anderson, Kenneth, Boccadoro, Mario, Richardson, Paul

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cardiovascular adverse events in modern myeloma therapy – Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)... gan Bringhen, Sara, Milan, Alberto, Ferri, Claudio, Wäsch, Ralph, Gay, Francesca, Larocca, Alessandra, Salvini, Marco, Terpos, Evangelos, Goldschmidt, Hartmut, Cavo, Michele, Petrucci, Maria Teresa, Ludwig, Heinz, Auner, Holger W., Caers, Jo, Gramatzki, Martin, Boccadoro, Mario, Einsele, Hermann, Sonneveld, Pieter, Engelhardt, Monika

Cael y testun llawn Cael y testun llawn Cael y testun llawn

European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma gan Bruno, Benedetto, Wäsch, Ralph, Engelhardt, Monika, Gay, Francesca, Giaccone, Luisa, D’Agostino, Mattia, Rodríguez-Lobato, Luis-Gerardo, Danhof, Sophia, Gagelmann, Nico, Kröger, Nicolaus, Popat, Rakesh, van de Donk, Niels W C J, Terpos, Evangelos, Dimopoulos, Meletios A, Sonneveld, Pieter, Einsele, Hermann, Boccadoro, Mario

Cael y testun llawn Cael y testun llawn Cael y testun llawn